Cerapedics Announces Positive Results From IDE Clinical Trial
Cerapedics is dedicated in the development of a novel osteobiologic (i-FACTOR™) that uses a unique platform of a peptide attachment factors, to enhance bone incorporation. The team at the Center for Spinal Disorders (Denver), were the lead investigators of this US FDA clinical study. Dr Michael Janssen (world renowned, board certified spine surgeon), lead FDA…